6. Health-related Consequences of Female Reproductive Aging. The menopause represents the end of a woman's reproductive years and is associated with a precipitous decline in circulating gonadal hormones, including estrogen and progesterone. Since women have live well past the average age at which the menopause occurs, a substantial portion of a woman's life is spent in a hormone-deprived state. Also, many neuronal populations are normal targets of hormones such as progesterone, and thus, it is likely that the depletion of such hormones would greatly impact brain function and may contribute age-related brain dysfunction. While considerable emphasis has been placed on estrogen protective actions on brain function, the involvement and mechanisms for progesterone action have been less well studied, but whose impact on brain function may be no less significant than that implicated for estrogen. In this proposal, we postulate that the GABAA receptor is a central player in progesterone's neuroprotective actions. Classically, progesterone modulates GABAA receptor function through its 5alpha-reduced metabolite, allopregnanolone, which enhances GABA-gated chloride currents. However, our preliminary data show that progesterone, and not ?allopregnanolone, rapidly and reversibly inhibits GABA-gated currents. Further, we offer preliminary data to suggest that this effect of progesterone may involve the activation of signal transduction pathways. Recently, we identified that progesterone elicits the activation of such neuroprotection-related signal transduction pathways as the Mitogen-activated protein kinase (MAPK) pathway. Since the GABAA receptor is a phosphoprotein, and that phosphorylation of the GABAA receptor results in altered channel function, we propose that progesterone inhibits the GABAA receptor by phosphorylating discrete sites within the GABAA receptor complex, through the activation of the MAPK signaling pathway. Furthermore, we hypothesized that progesterone-induced inhibition of the GABAA receptor is consistent with progesterone's neuroprotective actions. These hypotheses will be tested using recombinant GABAA receptors expressed in HEK298 cells, where we will evaluate: 1) The importance of the MAPK pathway in mediating progesterone's effects on GABAA receptor function, 2) If phosphorylation of specific sites within GABAA receptor subunits are critical fro progesterone's actions, and 3) If such phosphorylation events are critical for progesterone cytoprotective actions.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Small Research Grants (R03)
Project #
5R03AG023330-02
Application #
6839976
Study Section
National Institute on Aging Initial Review Group (NIA)
Program Officer
Petanceska, Suzana
Project Start
2004-01-01
Project End
2006-06-30
Budget Start
2005-01-01
Budget End
2006-06-30
Support Year
2
Fiscal Year
2005
Total Cost
$71,000
Indirect Cost
Name
University of North Texas
Department
Pharmacology
Type
Other Domestic Higher Education
DUNS #
110091808
City
Fort Worth
State
TX
Country
United States
Zip Code
76107
Su, Chang; Underwood, Wendy; Rybalchenko, Nataliya et al. (2011) ERK1/2 and ERK5 have distinct roles in the regulation of brain-derived neurotrophic factor expression. J Neurosci Res 89:1542-50
Jodhka, Parmeet K; Kaur, Paramjit; Underwood, Wendy et al. (2009) The differences in neuroprotective efficacy of progesterone and medroxyprogesterone acetate correlate with their effects on brain-derived neurotrophic factor expression. Endocrinology 150:3162-8
Kaur, Paramjit; Jodhka, Parmeet K; Underwood, Wendy A et al. (2007) Progesterone increases brain-derived neuroptrophic factor expression and protects against glutamate toxicity in a mitogen-activated protein kinase- and phosphoinositide-3 kinase-dependent manner in cerebral cortical explants. J Neurosci Res 85:2441-9
Gatson, Joshua W; Singh, Meharvan (2007) Activation of a membrane-associated androgen receptor promotes cell death in primary cortical astrocytes. Endocrinology 148:2458-64
Singh, M (2007) Progestins and neuroprotection: are all progestins created equal? Minerva Endocrinol 32:95-102
Singh, Meharvan (2006) Progesterone-induced neuroprotection. Endocrine 29:271-4
Bell-Horner, Cathy L; Dohi, Akiko; Nguyen, Quynh et al. (2006) ERK/MAPK pathway regulates GABAA receptors. J Neurobiol 66:1467-74
Gatson, Joshua W; Kaur, Paramjit; Singh, Meharvan (2006) Dihydrotestosterone differentially modulates the mitogen-activated protein kinase and the phosphoinositide 3-kinase/Akt pathways through the nuclear and novel membrane androgen receptor in C6 cells. Endocrinology 147:2028-34
Singh, Meharvan; Dykens, James A; Simpkins, James W (2006) Novel mechanisms for estrogen-induced neuroprotection. Exp Biol Med (Maywood) 231:514-21
Simpkins, J W; Yang, S-H; Wen, Y et al. (2005) Estrogens, progestins, menopause and neurodegeneration: basic and clinical studies. Cell Mol Life Sci 62:271-80

Showing the most recent 10 out of 11 publications